Hypodense or isodense to normal liver
•
Delayed scans
Mass: Isodense to normal liver
Central scar: Hyperdense or hyperintense (due to fibrous tissue)
•
Gadoxetate-enhanced MR
Most specific test to diagnose FNH
Prolonged enhancement of entire FNH (except scar) on delayed scan
TOP DIFFERENTIAL DIAGNOSES
•
Hepatic adenoma
Rarely retains gadoxetate on delayed phase MR
•
Fibrolamellar hepatocellular carcinoma
Usually large (> 12 cm) heterogeneous mass
Has “aggressive” features such as metastases
•
Hepatic cavernous hemangioma
Enhanced portions isodense to vessels
•
Hypervascular metastasis
Usually multiple with known primary tumor
DIAGNOSTIC CHECKLIST
•
Imaging is more reliable than histology in establishing diagnosis of FNH
•
Diagnosis can be made by CT alone in most cases
MR with gadoxetate enhancement is most specific test
TERMINOLOGY
Abbreviations
•
Focal nodular hyperplasia (FNH)
Definitions
•
Benign tumor of liver caused by hyperplastic response to localized vascular abnormality
IMAGING
General Features
•
Best diagnostic clue
Bright, homogeneously enhancing mass on arterial phase CT or MR with delayed enhancement of central scar
–
Hyperintense enhancement on hepatobiliary phase of gadoxetate-enhanced MR
•
Location
Usually subcapsular and rarely pedunculated
•
Size
Majority are < 5 cm unless symptomatic
•
Morphology
Spherical nonencapsulated mass
•
Key concepts
2nd most common benign tumor of liver
Benign congenital hamartomatous malformation
Accounts for 8% of primary hepatic tumors in autopsy series
Usually solitary lesion (80%); multiple (20%)
Multiple FNHs are associated with multiorgan vascular malformations and certain brain neoplasms
CT Findings
•
NECT
Isodense or hypodense to normal liver
•
CECT
Hepatic arterial phase scan
–
Transient, intense, homogeneous hyperdensity
Portal venous phase scan
–
Hypodense or isodense to normal liver
–
Large draining veins → hepatic veins
Delayed scans
–
Mass: ∼ isodense to normal liver
–
Central scar: Hyperdense (due to fibrous tissue)
–
Scar visible in 2/3 of large and 1/3 of small FNHs
“Large” > 3 cm
MR Findings
•
T1WI
Mass: Isointense to slightly hypointense
Central scar: Hypointense
•
T2WI
Mass: Slightly hyperintense to isointense
Central scar: Hyperintense
•
T1WI C+
Arterial phase: Hyperintense (homogeneous)
Portal venous: Isointense to liver
Delayed phase
•
Specific hepatobiliary MR contrast agents
Gadoxetate (Eovist or Primovist)
–
Bright, homogeneous enhancement of FNH on arterial phase
–
Prolonged enhancement of entire FNH on hepatobiliary phase (delayed, ∼ 20 minutes)
Intensity of FNH > liver
Most specific test to distinguish from all other hepatic masses
Due to functioning hepatocytes, malformed bile ductules
Ultrasonographic Findings
•
Grayscale ultrasound
Mass: Mostly homogeneous and isoechoic to liver
–
Occasionally hypoechoic or hyperechoic
Central scar: Hypoechoic
•
Color Doppler
Spoke-wheel pattern
–
Large central feeding artery with multiple small vessels radiating peripherally
Large draining veins at tumor margins
High-velocity Doppler signals
–
Due to increased blood flow or arteriovenous shunts
Get Clinical Tree app for offline access